These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22446832)
1. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer. Gao Q; Yang S; Kang MQ Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832 [TBL] [Abstract][Full Text] [Related]
2. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis. Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565 [TBL] [Abstract][Full Text] [Related]
3. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2]. Han PH; Li XJ; Qin H; Yao J; DU N; Ren H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395 [TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer]. Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases. Kren L; Brazdil J; Hermanova M; Goncharuk VN; Kallakury BV; Kaur P; Ross JS Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):44-9. PubMed ID: 15163019 [TBL] [Abstract][Full Text] [Related]
6. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features]. Wang L; Li X; Li Y; Xue YW Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808 [TBL] [Abstract][Full Text] [Related]
7. A multiple marker analysis of apoptosis-associated protein expression in non-small cell lung cancer in a Chinese population. Fan CF; Xu HT; Lin XY; Yu JH; Wang EH Folia Histochem Cytobiol; 2011; 49(2):231-9. PubMed ID: 21744322 [TBL] [Abstract][Full Text] [Related]
8. Expression of Elf-1 and survivin in non-small cell lung cancer and their relationship to intratumoral microvessel density. Yang DX; Li NE; Ma Y; Han YC; Shi Y Chin J Cancer; 2010 Apr; 29(4):396-402. PubMed ID: 20346215 [TBL] [Abstract][Full Text] [Related]
9. [Subcellular localization of survivin in non-small cell lung cancer]. He L; Hou M; Zhang J; Xu N; Chen P Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914 [TBL] [Abstract][Full Text] [Related]
10. Survivin expression impacts prognostically on NSCLC but not SCLC. Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791 [TBL] [Abstract][Full Text] [Related]
11. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis. Zhou XL; Wang M Genet Mol Res; 2015 Dec; 14(4):17059-67. PubMed ID: 26681053 [TBL] [Abstract][Full Text] [Related]
12. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis. Ulukus EC; Kargi HA; Sis B; Lebe B; Oztop I; Akkoclu A; Onen A; Sanli A Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):31-7. PubMed ID: 17536304 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy. Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822 [TBL] [Abstract][Full Text] [Related]
14. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer]. Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585 [TBL] [Abstract][Full Text] [Related]
15. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis. Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related]
18. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis. Chen P; Zhu J; Liu DY; Li HY; Xu N; Hou M Med Oncol; 2014 Jan; 31(1):775. PubMed ID: 24338338 [TBL] [Abstract][Full Text] [Related]
19. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer]. Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277 [TBL] [Abstract][Full Text] [Related]
20. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer. Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]